Condition
Neoplasms, Endometrial clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Neoplasms, Endometrial clinical trials that are recruiting, at sites in 11 countries (most in Canada (2), Japan (2), South Korea (2)). By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 11Countries
Newest Neoplasms, Endometrial clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Maintenance mocertatug rezetecan with immune therapy for endometrial cancer | Phase 3 | Toronto, Ontario and 11 other locations | Recruiting | Jul 6, 2026 |
| Mo-Rez vs chemotherapy for endometrial cancer after platinum-based therapy | Phase 3 | Birmingham, Alabama and 55 other locations | Recruiting | Dec 16, 2025 |
| Dostarlimab with carboplatin–paclitaxel for advanced or recurrent endometrial cancer in Chinese patients with dMMR/MSI-H | Phase 2 | Jinan, Shandong | Recruiting | Aug 7, 2025 |
All recruiting trials (3)
-
Maintenance mocertatug rezetecan with immune therapy for endometrial cancer
This study tests whether adding Mocertatug Rezetecan to the physician’s chosen immunotherapy helps people with advanced or recurrent endometrial cancer stay on maintenance treatment longer.
-
Mo-Rez vs chemotherapy for endometrial cancer after platinum-based therapy
In people with endometrial cancer who have already had platinum therapy, this study tests mocertatug rezetecan (Mo-Rez) against standard chemotherapy to see how well it works and how safe it is.
-
Dostarlimab with carboplatin–paclitaxel for advanced or recurrent endometrial cancer in Chinese patients with dMMR/MSI-H
This Phase 2 trial will test whether adding dostarlimab to carboplatin and paclitaxel helps Chinese patients with advanced or recurrent dMMR/MSI‑H endometrial cancer respond to treatment and tolerate the combination.
Related topics
Quick answers
How many Neoplasms, Endometrial clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in Canada (2 trials), Japan (2 trials), South Korea (2 trials), Argentina (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.